(Q34088545)

English

Expression of herstatin, an autoinhibitor of HER-2/neu, inhibits transactivation of HER-3 by HER-2 and blocks EGF activation of the EGF receptor

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

Expression of herstatin, an autoinhibitor of HER-2/neu, inhibits transactivation of HER-3 by HER-2 and blocks EGF activation of the EGF receptor (English)

1 reference

Europe PubMed Central

30 July 2017

0 references

author name string

Azios NG

1

1 reference

Europe PubMed Central

30 July 2017

Romero FJ

2

1 reference

Europe PubMed Central

30 July 2017

Denton MC

3

1 reference

Europe PubMed Central

30 July 2017

Doherty JK

4

1 reference

Europe PubMed Central

30 July 2017

Clinton GM

5

1 reference

Europe PubMed Central

30 July 2017

language of work or name

0 references

publication date

1 August 2001

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

20

1 reference

Europe PubMed Central

30 July 2017

5199-5209

1 reference

Europe PubMed Central

30 July 2017

37

1 reference

Europe PubMed Central

30 July 2017

https://scigraph.springernature.com/pub.10.1038/sj.onc.1204555

0 references

Growth factors and cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

21 January 2018

Type I receptor tyrosine kinases as targets for therapy in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

21 January 2018

Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

21 January 2018

Tissue-specific transformation by oncogenic mutants of epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

21 January 2018

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

21 January 2018

erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

21 January 2018

The HER-2/neu receptor tyrosine kinase gene encodes a secreted autoinhibitor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

21 January 2018

Signalling by receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

21 January 2018

Formation of a high affinity heregulin binding site using the soluble extracellular domains of ErbB2 with ErbB3 or ErbB4.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

21 January 2018

ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

21 January 2018

Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

21 January 2018

Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

21 January 2018

Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

21 January 2018

Ligand-induced dimerization of growth factor receptors: variations on the theme

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

21 January 2018

Identification of heregulin, a specific activator of p185erbB2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

21 January 2018

Amplified expression of the HER2/ERBB2 oncogene induces resistance to tumor necrosis factor alpha in NIH 3T3 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

21 January 2018

Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

21 January 2018

Suppression and promotion of tumor growth by monoclonal antibodies to ErbB-2 differentially correlate with cellular uptake

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

21 January 2018

A dominant negative mutation suppresses the function of normal epidermal growth factor receptors by heterodimerization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

21 January 2018

Localization of a major receptor-binding domain for epidermal growth factor by affinity labeling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

21 January 2018

Two EGF molecules contribute additively to stabilization of the EGFR dimer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

21 January 2018

Trans receptor inhibition of human glioblastoma cells by erbB family ectodomains.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

21 January 2018

The ErbB signaling network: receptor heterodimerization in development and cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

21 January 2018

Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

21 January 2018

Isolation of the neu/HER-2 stimulatory ligand: a 44 kd glycoprotein that induces differentiation of mammary tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

21 January 2018

ErbB tyrosine kinases and the two neuregulin families constitute a ligand-receptor network.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

21 January 2018

Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu: a mechanism of interreceptor kinase activation and transphosphorylation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

21 January 2018

Specificity within the EGF family/ErbB receptor family signaling network

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

21 January 2018

The cellular response to neuregulins is governed by complex interactions of the erbB receptor family

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

21 January 2018

Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

21 January 2018

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

21 January 2018

Endocytosis of growth factor receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

21 January 2018

ErbB2 is necessary for induction of carcinoma cell invasion by ErbB family receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

21 January 2018

Dimerization of the extracellular domain of the receptor for epidermal growth factor containing the membrane-spanning segment in response to treatment with epidermal growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

21 January 2018

Bivalence of EGF-like ligands drives the ErbB signaling network

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

21 January 2018

A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

21 January 2018

Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

21 January 2018

Direct identification of residues of the epidermal growth factor receptor in close proximity to the amino terminus of bound epidermal growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

21 January 2018

Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

7 January 2021

based on heuristic

inferred from DOI database lookup

The biology of erbB-2/neu/HER-2 and its role in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of breast tumour development in vivo by downregulation of the p185neu receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

7 January 2021

based on heuristic

inferred from DOI database lookup

Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

7 January 2021

based on heuristic

inferred from DOI database lookup

Functional analysis of the ligand binding site of EGF-receptor utilizing chimeric chicken/human receptor molecules.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

7 January 2021

based on heuristic

inferred from DOI database lookup

Noncontiguous regions in the extracellular domain of EGF receptor define ligand-binding specificity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

7 January 2021

based on heuristic

inferred from DOI database lookup

Domain-specific Interactions between the p185neuand Epidermal Growth Factor Receptor Kinases Determine Differential Signaling Outcomes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

7 January 2021

based on heuristic

inferred from DOI database lookup

A book that disturbed me

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

7 January 2021

based on heuristic

inferred from DOI database lookup

Amplification of c-erbB-2 and aggressive human breast tumors?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of transfected DNA depends on DNA topology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

7 January 2021

based on heuristic

inferred from DOI database lookup

Augmentation of a humanized anti-HER2 mAb 4D5 induced growth inhibition by a human-mouse chimeric anti-EGF receptor mAb C225

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204555

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.ONC.1204555

1 reference

Europe PubMed Central

30 July 2017

Dimensions Publication ID

0 references

release_avfwjpcptbcztdleehtmm5zuqq

1 reference

https://api.fatcat.wiki/v0/release/avfwjpcptbcztdleehtmm5zuqq

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34088545&oldid=2039027819"